“Fibermaxxing” social media trend is making people talk about dietary fiber. What does science really say?
19 Nov 2025by GMFH Editing Team
Across social media, #fibermaxxing is inspiring people to boost their daily fiber intake. While enthusiasm for healthier eating is positive, this trend also invites an important question: what does science really say about fiber, microbiota, and health?
Vaccines have been protecting us from infectious diseases for over 200 years. Interestingly, recent research suggests unexpected players may be at work behind the scenes: the trillions of microbes that comprise our gut microbiota. Researchers continue to explore how gut microbiota influence immunity, why vaccine responses vary, and whether diet and prebiotics can tip the balance in our favour.
This Halloween, we’re celebrating some microbes that sound scary but play a vital role in keeping us healthy. Behind their ghostly names lie fascinating stories of cooperation, balance, and invisible teamwork inside our gut.
Stay tuned to our latest news
Food 4 Gut Health news
Emerging studies suggest the gut microbiome may predict how well you age. The world’s oldest person offers scientists new clues into the secrets of healthy aging and protection against the diseases that often plague the final years of life.
Why gluten and wheat may not be the dietary villains driving IBS symptoms
25 Nov 2025by Andreu Prados
Although the underlying cause of irritable bowel syndrome is unclear, many people with IBS believe they are sensitive to gluten or wheat. A new study finds gluten and wheat are safe for many people with IBS, and the culprit might be something else.
Research & Practice news
From colonic food to systems biology: the 30th anniversary of the prebiotic concept
17 Dec 2025by Mónica Quinzo
The definition of a prebiotic has evolved from a focus on colonic fiber to a complex ecological strategy. This article traces the concept's 30-year journey, highlighting the shift from non-digestible carbohydrates to the latest expert recommendations.
Imidazole propionate: a novel driver of atherosclerosis and biomarker of subclinical disease
4 Dec 2025by Andreu Prados
Cardiovascular diseases remain one of the most pressing public health concerns, demanding innovative research to identify novel causes. A recent Nature study reported that imidazole propionate made by gut bacteria contributes to atherosclerosis development, supporting its potential role as a biomarker of subclinical disease.
Fecal microbiota transplantation unable to induce remission at 8 weeks in adults with Crohn’s disease
17 Nov 2025by Karen Madsen
Previous clinical studies have shown a promising role of fecal microbiota transplantation to induce remission in ulcerative colitis and maintain steroid-induced Crohn’s disease remission. A new double-blind, placebo-controlled trial found fecal microbiota transplantation is not effective at inducing clinical or endoscopic remission in adults with Crohn’s disease.
